WBB Securities Sponsors BioCentury’s 2016 Future Leaders Conference
Posted: Mar 1st, 2016In: Press ReleasesWBB Securities is a sponsor of this year’s Future Leader’s conference.
Read More about WBB Securities Sponsors BioCentury’s 2016 Future Leaders ConferenceWBB Securities Acts as Co-manager for $100 Million in Public Offering for Cempra Pharmaceuticals
Posted: Jan 12th, 2016In: Press ReleasesWBB Securities acted as co-manager to a transaction for Cempra Pharmaceuticals, a clinical-stage biopharmaceutical company focused on discovering and developing novel antibiotics.
Read More about WBB Securities Acts as Co-manager for $100 Million in Public Offering for Cempra PharmaceuticalsWBB Securities Sponsors BioCentury’s Annual NewsMakers Conference
Posted: Sep 1st, 2015In: Press ReleasesWBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference.
Read More about WBB Securities Sponsors BioCentury’s Annual NewsMakers ConferenceWBB Securities Acts as Financial Advisor on $60 Million Loan for Navidea Biopharmaceuticals
Posted: May 11th, 2015In: Press ReleasesWBB Securities acted as financial advisor to Navidea Biopharmaceuticals regarding a term loan with CRG (formerly Capital Royalty LP). Under the terms of the agreement, CRG will provide Navidea with initial funding of $50[...]
Read More about WBB Securities Acts as Financial Advisor on $60 Million Loan for Navidea BiopharmaceuticalsWBB Securities Acts as Placement Agent for up to $25 Million in Equity Financing for Cytori Therapeutics
Posted: May 8th, 2015In: Press ReleasesWBB Securities acted as placement agent to a transaction for Cytori Therapeutics, a clinical-stage biopharmaceutical company focused on discovering and developing autologous cell therapies from adipose tissue to treat a variety of medical conditions.
Read More about WBB Securities Acts as Placement Agent for up to $25 Million in Equity Financing for Cytori TherapeuticsWBB Securities Sponsors BioCentury’s Future Leaders in the Biotech Industry Conference
Posted: Mar 20th, 2015In: Press ReleasesToday WBB Securities sponsored BioCentury’s Future Leaders in the Biotech Industry conference held at the Millennium Broadway Hotel and Conference Center in New York City.
Read More about WBB Securities Sponsors BioCentury’s Future Leaders in the Biotech Industry ConferenceWBB Securities Co-Manages $84 Million Public Offering for Omeros Corporation
Posted: Feb 4th, 2015In: Press ReleasesWBB Securities acted as co-manager to a transaction for Omeros Corporation in an underwritten public offering that closed on February 3, 2015.
Read More about WBB Securities Co-Manages $84 Million Public Offering for Omeros CorporationWBB Securities Co-Manages $10.3MM Public Offering for CytoSorbents Corporation
Posted: Jan 15th, 2015In: Press ReleasesCytoSorbents announces closing of public offering to fund ongoing commercial and clinical activities
Read More about WBB Securities Co-Manages $10.3MM Public Offering for CytoSorbents CorporationWBB Securities Announces Michelle Thomas Elected to FINRA District 2 Committee
Posted: Dec 8th, 2014In: Press ReleasesWBB Securities is pleased to announce that Michelle Thomas, CRCPhas been elected to the FINRA District 2 Committee where she will serve a three-year term.
Read More about WBB Securities Announces Michelle Thomas Elected to FINRA District 2 CommitteeWBB Securities Acts as Financial Advisor to NeoStem, Inc. on $20MM Debt Facility
Posted: Sep 29th, 2014In: Press ReleasesNeoStem announces $20 million term loan financing from Oxford Finance LLC
Read More about WBB Securities Acts as Financial Advisor to NeoStem, Inc. on $20MM Debt Facility